Lung metastasis from hepatocellular carcinoma is the most common among hepatocellular carcinoma metastases. Follow-up of 323 patients with hepatocellular carcinoma operated between 1972 and 1995 reportedly showed that the incidence of hepatocellular carcinoma lung metastasis was 12.6%. 9 patients with hepatocellular carcinoma had their isolated recurrent lung foci surgically resected and were treated with adjuvant chemotherapy after surgery, and the mean survival time of the patients was 40 months, and the 5-year survival rate after surgery reached 67%. Clinical reports have treated 12 patients with surgical resection of isolated recurrent foci present in the lung or abdominal cavity with a mean survival time of 20 months and 6 patients surviving tumor-free for more than 1 year. The efficacy achieved in these reports is certainly encouraging. However, the prerequisites for surgical treatment are: firstly, the lung recurrent foci are isolated, limited and capable of radical resection; secondly, the presence of recurrent foci in other sites must be carefully excluded, and the number of patients meeting such conditions is very few, and most patients mostly take postoperative Chinese medicine combined with chemotherapy to have a chance of long-term quality life. chemotherapy simultaneously reflect their respective values. Therefore, for most patients, including those with liver cancer lung metastasis, surgery, Chinese medicine and chemotherapy are of equal value. The specific treatment method should be analyzed according to the patient’s specific situation.